Clinical trials: Oncologic Patients
Cutaneous Melanoma, Mucosal Melanoma
Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma
- Trial name
- ARTISTRY-6 (NCT04830124)
- Testing
- Nemvaleukin Alfa Subcutaneous, Nemvaleukin Alfa Intravenous, Nemvaleukin Alfa Intravenous Less Frequent Dosing
- Where
- 41 sites in United States, Australia and 6 more
- Volunteers
- 173 people
- Sponsor
- Mural Oncology, Inc
Anxiety, Quality of Life
Using Meditation for Oncology Anxiety
The current study is a prospective, interventional, randomized, treatment-controlled study, evaluating the use of Meditation with a Mantra (MM) to decrease anxiety levels and improve Quality of Life (QOL) in prostate cancer…
- Conditions
- Anxiety, Quality of Life, Prostate Cancer, Prostate Cancer Recurrent
- Trial name
- NCT04312191
- Testing
- Mantra Meditation
- Sponsor
- Mellar Davis MD
Gynecologic Cancer, Chemotherapy Effect
Improve Cancer-related Cognitive Impairment
Cancer-related cognitive impairment (CRCI), also known as "chemobrain," is the cognitive decline that negatively impacts the majority of cancer patients undergoing chemotherapy, radiation, and/or hormonal treatments.
- Conditions
- Gynecologic Cancer, Chemotherapy Effect, Chemo-brain, Cancer-related Cognitive Difficulties
- Trial name
- NCT05864274
- Testing
- Cognitive training application
- Where
- United States
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- University of Alabama at Birmingham
Solid Tumor, Solid Tumor, Adult
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
The purpose of this study is to translate and tailor for Latinx participants a program called Communicating with Oncology Nurses about Values from the Outset (CONVO).
- Conditions
- Solid Tumor, Solid Tumor, Adult, Solid Tumor, Unspecified, Adult
- Trial name
- NCT04942717
- Testing
- CONVO intervention
- Where
- 5 sites in United States
- Volunteers
- 234 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Serology Analysis, Novel H1N1 Influenza Vaccination
Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients
The patients of pediatric haemato-oncology have a higher risk for novel H1N1 influenza infection than general population, and they are strongly recommended to receive novel H1N1 vaccination.
- Conditions
- Serology Analysis, Novel H1N1 Influenza Vaccination, Pediatric Haemato-oncology Patients
- Trial name
- NCT01046227
- Testing
- Influenza A (H1N1) 2009 monovalent vaccine, inactivated
- Where
- Taiwan
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- National Taiwan University Hospital
Oncologic Diseases, Cancer
Analysis of the Determinants of the Participation of Patients and Health Professionals of the University Hospital Center of Martinique in Clinical Research Protocols in Medical Oncology (StudyOrec)
For optimal patient care, it is imperative that healthcare professionals implement appropriate strategies. These strategies must take into account changes in healthcare practices associated with advances in medications and…
- Conditions
- Oncologic Diseases, Cancer, Oncology
- Trial name
- NCT07206927
- Testing
- Qualitative Study: Semi-structured interview for patients, Quantitative Study : Healthcare professionals questionnaires
- Where
- Martinique
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- University Hospital Center of Martinique
Cancer
Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer
Phase 1 Open-label treatment with MPC-2130 for subjects with refractory cancer.
- Trial name
- NCT00387153
- Testing
- MPC-2130
- Where
- United States
- Volunteers
- 8 people
- Sponsor
- Myriad Therapeutics, Inc.
Cancer
The National Oncologic PET Registry
The Centers for Medicare \& Medicaid Services (CMS), as the Federal agency that administers the Medicare program, only pays for positron emission tomography (PET) scans in patients with cancer for certain reasons and for certain…
- Trial name
- NOPR (NCT00868582)
- Testing
- PET scanning in cancer
- Where
- United States
- Volunteers
- 333,000 people
- Sponsor
- American College of Radiology Imaging Network
Gastric Cancer, Gastric (Stomach) Cancer
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer.
- Conditions
- Gastric Cancer, Gastric (Stomach) Cancer, Gastric Cancer (Diagnosis)
- Trial name
- ECLIPSE-CG (NCT07481110)
- Where
- 15 sites in Algeria
- Volunteers
- 1,000 people
- Sponsor
- Société Algérienne de Formation et Recherche en Oncologie
Multiple Myeloma
A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM
NDS-MM-004 is a multi-center, randomized, pilot trial to evaluate the MyHOPE for multiple myeloma (MM) Platform in patients with MM.
- Trial name
- MyHOPE™ (NCT04730505)
- Testing
- MyHOPE™ for Multiple Myeloma, MyHope HCP Portal
- Where
- 34 sites in United States
- Volunteers
- 2 people
- Sponsor
- Celgene
Solid Tumours
Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment
This is a 2-part study in patients with advanced solid tumours. Part A will investigate the PK of olaparib in patients with mild or moderate hepatic impairment compared to patients with normal hepatic function; Part B will allow…
- Trial name
- NCT01894243
- Testing
- Olaparib tablet dosing
- Where
- 12 sites in Czechia, France and 3 more
- Volunteers
- 31 people
- Sponsor
- AstraZeneca
Colorectal Cancer
REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis
In colorectal surgery about 30% of postoperative mortality is attributed to anastomotic leak, whit an incidence range between 1.8% and 15.9%.
- Trial name
- ANASTOSEAL (NCT03380858)
- Testing
- colectomy
- Where
- Italy
- Volunteers
- 390 people, healthy volunteers welcome
- Sponsor
- National Cancer Institute, Naples
Oncology, Adapted Physical Activity
Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer
The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.
- Trial name
- APPAHOCA (NCT03473652)
- Testing
- Adapted walking platform
- Where
- 2 sites in France
- Volunteers
- 45 people
- Sponsor
- Centre Francois Baclesse
Advanced Solid Tumor
An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
This open label, dose escalation module will evaluate the safety, tolerability, PK, PD, and preliminary efficacy of PTT-4256 in participants with solid tumours using a combination of accelerated dose titration (ADT) and Bayesian…
- Trial name
- NCT06634849
- Testing
- PTT-4256
- Where
- 5 sites in Australia
- Volunteers
- 30 people
- Sponsor
- Pathios Therapeutics Pty Ltd
Febrile Neutropenia, Neutropenia
Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients
Febrile neutropenia (FN) is a major life-threatening treatment complication in cancer patients undergoing intensive chemotherapy. Endogenous flora is considered to be one of the main sources of infections during neutropenia.
- Conditions
- Febrile Neutropenia, Neutropenia, Infection in an Immunocompromised Host, Cancer
- Trial name
- FENSY (NCT02544685)
- Testing
- Probio-Fix Inum, Beneo Synergy 1
- Where
- Slovakia
- Volunteers
- 120 people
- Sponsor
- S&D Pharma SK s.r.o.
Cancer Metastatic, Cancer
Telerehabilitation in Oncology Patients
The aim is to analyze the feasibility and effect of an online Therapeutic Exercise and Education programme (TEEP) in cancer patient and survivors
- Conditions
- Cancer Metastatic, Cancer, Survivorship
- Trial name
- NCT04547634
- Testing
- Therapeutic Exercise and Education
- Where
- Spain
- Volunteers
- 30 people
- Sponsor
- University of Malaga
Advanced Malignancy, Advanced Solid Tumors
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
This is a Phase 1 dose escalation to assess the safety, tolerability and maximum tolerated dose of subcutaneous administered SDX-7320 in patients with advanced refractory or late-stage solid tumors.
- Conditions
- Advanced Malignancy, Advanced Solid Tumors, Neoplasm, Metastasis
- Trial name
- SDX-0101 (NCT02743637)
- Testing
- SDX-7320
- Where
- 3 sites in United States
- Volunteers
- 32 people
- Sponsor
- SynDevRx, Inc.
MRSA Colonization, VRE Colonization
The Effect of Chlorhexidine Bathing on MRSA and VRE Colonization Among Haematology-Oncology ICU Patients
Hospital-acquired infections (HIs) are defined as an infection developed within 48-72 hours of admission to hospital in whom the infection was not incubating at the time of admission to the hospital or an infection acquired in…
- Trial name
- NCT04347057
- Testing
- Bed bathing with 2% CHG solution, Bed bathing with soap and water
- Where
- Turkey (Türkiye)
- Volunteers
- 78 people
- Sponsor
- Hacettepe University
Covid-19, Cancer
Screening of Cancer Patients to Assess Impact of COVID-19
The purpose of this study is to investigate the impact of COVID -19 in the cancer patient population. This will be done by looking at the rate of asymptomatic COVID-19 infection in cancer patients receiving cancer therapy, as…
- Trial name
- NCT04373005
- Testing
- Nasopharyngeal (NP) swab
- Where
- Canada
- Volunteers
- 83 people
- Sponsor
- University Health Network, Toronto
Cancer
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are…
- Trial name
- TIOB (NCT05371756)
- Where
- 8 sites in United States
- Volunteers
- 10,000 people
- Sponsor
- Baylor Research Institute
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.